These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39147280)
1. Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis. Zhang W; Zhang W; Deng Y; Gu N; Qiu Z; Deng C; Yang S; Pan L; Long S; Wang Y; Zhao Y; Shi B Int J Cardiol; 2024 Dec; 416():132451. PubMed ID: 39147280 [TBL] [Abstract][Full Text] [Related]
2. Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography. Zhang W; Zhang W; Gu N; Qiu Z; Pan L; Zhao Y; Shi B J Cardiovasc Pharmacol; 2024 Jun; 83(6):646-654. PubMed ID: 38030142 [TBL] [Abstract][Full Text] [Related]
3. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis. Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557 [TBL] [Abstract][Full Text] [Related]
4. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549 [TBL] [Abstract][Full Text] [Related]
5. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis. Nakamura D; Dohi T; Ishihara T; Kikuchi A; Mori N; Yokoi K; Shiraki T; Mizote I; Mano T; Higuchi Y; Yamada T; Nishino M; Sakata Y EuroIntervention; 2021 Aug; 17(6):489-496. PubMed ID: 32985411 [TBL] [Abstract][Full Text] [Related]
6. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation]. Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937 [No Abstract] [Full Text] [Related]
7. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
8. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis. de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis. Wu H; Yu T; Fan T; Liao W Comput Math Methods Med; 2022; 2022():9832622. PubMed ID: 36238492 [TBL] [Abstract][Full Text] [Related]
10. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents. Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026 [TBL] [Abstract][Full Text] [Related]
11. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447 [TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis. Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217 [TBL] [Abstract][Full Text] [Related]
13. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study. Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379 [TBL] [Abstract][Full Text] [Related]
14. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting. Chen T; Sun JL; Zhang J Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235 [TBL] [Abstract][Full Text] [Related]
15. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI. Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation. Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946 [TBL] [Abstract][Full Text] [Related]
18. [OCT analysis of in-stent neointima over 5 years post-DES implantation]. Han Y; Yuan XH; Jiang MT; Feng HH; Zhang X; Zhang YQ; Jing J; Chen YD; Gao L Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb; 52(2):150-157. PubMed ID: 38326066 [No Abstract] [Full Text] [Related]
19. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss. Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119 [TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance. Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Ibuki M; Hasegawa K; Ishibuchi K; Tamaru H; Yasuda S; Ishii R; Nakabayashi S; Kusumoto H; Higashino Y Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]